Constellation Investments’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$1.57M Buy
21,800
+400
+2% +$30.3K 0.29% 73
2015
Q4
$1.8M Buy
21,400
+400
+2% +$33.2K 0.34% 68
2015
Q3
$1.76M Hold
21,000
0.36% 64
2015
Q2
$1.75M Buy
21,000
+300
+1% +$22.9K 0.33% 70
2015
Q1
$1.5M Buy
20,700
+800
+4% +$57K 0.29% 78
2014
Q4
$1.37M Buy
19,900
+800
+4% +$54K 0.28% 82
2014
Q3
$1.24M Buy
19,100
+300
+2% +$19K 0.28% 80
2014
Q2
$1.17M Buy
18,800
+300
+2% +$17.9K 0.27% 89
2014
Q1
$1.09M Buy
18,500
+300
+2% +$16.7K 0.26% 87
2013
Q4
$928K Buy
18,200
+1,300
+8% +$65.1K 0.24% 93
2013
Q3
$851K Buy
16,900
+1,000
+6% +$52.4K 0.26% 90
2013
Q2
$781K Buy
+15,900
New +$865K 0.27% 83

Other funds holding LLY

Constellation Investments's LLY Position: Q1 2016 in Review

Constellation Investments increased its Eli Lilly (LLY) stake by 1.9% in Q1 2016, buying an estimated $30.3K and bringing the position to 21,800 shares worth $1.57M. The position accounts for 0.29% of the portfolio, ranked #73.

Constellation Investments first reported a position in LLY in Q2 2013 and has held it in 12 quarters since. The position peaked at $1.8M in Q4 2015. 1,151 funds tracked by Wall St. Rank hold LLY as of Q1 2016.

  • Constellation Investments held 21,800 shares of Eli Lilly worth $1.57M as of Q1 2016.
  • Constellation Investments bought 400 Eli Lilly shares in Q1 2016, an estimated $30.3K.
  • Eli Lilly made up 0.29% of Constellation Investments's portfolio in Q1 2016, its #73 holding.
  • Constellation Investments first reported a position in Eli Lilly in Q2 2013 and has held it in 12 quarters since.
  • Constellation Investments's Eli Lilly position peaked at $1.8M in Q4 2015.
  • 1,151 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2016.

Based on Constellation Investments's 13F filing for Q1 2016, filed 28 Apr 2016.